Physician profile
Gretchen D Eichenlaub
NPI 1922277748
$3,129.78
in general payments reported to CMS, 2019-2025
23 companies · $417 in 2025
The $417 reported for 2025 was more than what 82% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $715 · 2022: $747 · 2023: $780 · 2024: $472 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $512.78 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $393.73 | 2021-2025 | |
| Abbvie INC. | $308.62 | 2021-2023 | |
| Astellas Pharma US INC | $248.19 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $231.96 | 2021-2024 | Slynd |
| Sumitomo Pharma America, INC. | $183.78 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $149.40 | 2021-2022 | |
| Organon LLC | $146.52 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $145.54 | 2021-2025 | Acessa Provu System, Aptima |
| Mylan Pharmaceuticals INC. | $130.68 | 2021-2022 | |
| Aspira Women'S Health INC | $114.20 | 2022-2023 | Ova1 |
| Agile Therapeutics, INC. | $94.45 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $79.14 | 2021-2022 | |
| Millicent US INC | $76.59 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Evofem Biosciences, INC. | $64.99 | 2021-2023 | Phexxi |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $61.45 | 2023-2025 | |
| Exact Sciences Corporation | $43.68 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $39.19 | 2024 | |
| Dexcom, INC. | $29.43 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $25.17 | 2021 | |
| Scynexis, INC. | $20.94 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.97 | 2023 | Exparel |
| Axonics, INC. | $13.38 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Eichenlaub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.